Long-Acting Bronchodilator Use in Chronic Obstructive Pulmonary Disease in Primary Care in New Zealand: A Retrospective Study of Treatment Patterns and Evolution Using the HealthStat Database

Long-Acting Bronchodilator Use in Chronic Obstructive Pulmonary Disease in Primary Care in New Zealand: A Retrospective Study of Treatment Patterns and Evolution Using the HealthStat Database

Dominique Milea,1 See-Hwee Yeo,1 Yein Nam,2 Aldo Amador Navarro Rojas,1 Sumitra Shantakumar,1 Janine Beale,3 Brett Marett,3 Robert P Young,4 Raewyn J Scott,4 Barry Gribben5 1Value Evidence and Outcomes, GlaxoSmithKline plc., Greater China and Intercontinental, 139234, Singapore; 2Real World Evidence...

Full description

Bibliographic Details
Main Authors: Milea D, Yeo SH, Nam Y, Navarro Rojas AA, Shantakumar S, Beale J, Marett B, Young RP, Scott RJ, Gribben B
Format: Article
Language:English
Published: Dove Medical Press 2021-04-01
Series:International Journal of COPD
Subjects:
bronchodilator therapy
chronic obstructive pulmonary disease
long-acting muscarinic antagonist
long-acting β2-agonist
inhaled corticosteroid
new zealand
Online Access:https://www.dovepress.com/long-acting-bronchodilator-use-in-chronic-obstructive-pulmonary-diseas-peer-reviewed-fulltext-article-COPD

Internet

https://www.dovepress.com/long-acting-bronchodilator-use-in-chronic-obstructive-pulmonary-diseas-peer-reviewed-fulltext-article-COPD

Similar Items